Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows a newer ClinicalTrials.gov revision/build number (“v3.5.3”), replacing the previous (“v3.5.2”). This represents a backend/UI version bump rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-04-24T22:40:15.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:18:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:41:47.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-05T18:28:56.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the government funding lapse notice and Revision: v3.4.1 were removed.
    Difference
    0.2%
    Check dated 2026-02-11T09:53:40.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A site-wide funding status notice was added, and the page was updated to Revision: v3.4.1 (replacing v3.4.0).
    Difference
    0.2%
    Check dated 2026-02-04T06:35:36.000Z thumbnail image

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.